Circulating SIRT6 Expression, Effect on Aging Quality

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-03-31

Study Completion Date

2012-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study follows the results of the COMPALICLAMP study (NCT00951392) where the investigators showed a differential expression of sirtuins protein isoforms, Sirt6, in muscle depending on the quality of aging. The investigators seek to confirm this difference in expression level of circulating leukocytes on a larger sample.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Antioxidants and Pulmonary Rehabilitation in COPD Patients

NCT01942889

Chronic Obstructive Pulmonary Disease COPD

COMPLETED NA

The SaVe Project-Sarcopenia and Vertigo in Aging Patients With Colorectal Cancer

NCT05710809

Colorectal Cancer Oncologic Complications Comprehensive Geriatric Assessment +19 more

RECRUITING NA

Chen-style Tai Chi in Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease

NCT02370654

Chronic Obstructive Pulmonary Disease (COPD)

COMPLETED NA

Validating the Use of Frailty Measurements to Predict Care & Quality of Life

NCT06325241

Chronic Obstructive Pulmonary Disease

ACTIVE_NOT_RECRUITING

Severe Chronic Respiratory Failure and Citrulline

NCT03694964

Pulmonary Disease, Chronic Obstructive

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aging

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Single Arm

Group Type OTHER

Blood sample

Intervention Type BIOLOGICAL

It is a single cross sectional study. All outcome measures will be taken during the investigation with physical examination, questionnaire and a blood sample

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood sample

It is a single cross sectional study. All outcome measures will be taken during the investigation with physical examination, questionnaire and a blood sample

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Volunteers from the SUVIMAX 2 aging cohort
* Men and women
* Older than 60
* Subject with a global aging quality score of 1 or 3 in the SU.VI.MAX. 2 study
* Covered by Health Insurance System